1 no longer available. .
Follow Joseph Antin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CliniMACS® CD34+ Reagent System for Expanded Access Use CliniMACS CD34 Reagent System - Graft-Versus-Host Disease(GVHD), Anemia Due to Disturbance of Proliferation and/or Differentiation of Hematopoietic Stem Cells | No longer available | Joseph Antin | 2013-03-01 | 2016-11-21 |
Delayed Graft Function (1) · Graft vs Host Disease (1)
United States (1)